ZyVersa Therapeutics, Inc. (ZVSA)

OTCMKTS · Delayed Price · Currency is USD

0.140

0.00 (0.00%)

At close: Dec 5, 2025

ZyVersa Therapeutics Employees

ZyVersa Therapeutics had 7 employees as of December 31, 2024. The number of employees did not change compared to the previous year.

Employees

7

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

n/a

Profits / Employee

-$3,670,786

Market Cap

1.13M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	7	0	-
Dec 31, 2023	7	0	-
Dec 31, 2022	7	-	-

Related Stocks

Company Name	Employees
Elite Pharmaceuticals	68
Glass House Brands	374
CytoDyn	13
American Oncology Network	1,914
Northwest Biotherapeutics	25
Silence Therapeutics	116
Zomedica	152

Employee Rankings

ZyVersa Therapeutics News

16 days ago - ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
3 months ago - ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes - GlobeNewsWire
3 months ago - ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression - GlobeNewsWire
4 months ago - ZyVersa Therapeutics Highlights Data Demonstrating a Critical Need for Therapies to Address Kidney Lipotoxicity to Alleviate Diabetic Kidney Disease (DKD) and Its Progression - GlobeNewsWire
4 months ago - ZyVersa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-term Value-building Milestones - GlobeNewsWire
4 months ago - ZyVersa Therapeutics CEO Issues Mid-year Shareholder Letter Highlighting Recent Corporate Developments and R&D Progress - GlobeNewsWire
5 months ago - Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? - Benzinga
5 months ago - ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds - GlobeNewsWire